Kolexia
Roue-Quintin Isabelle
Anatomie et cytologie
Hôpital Morvan
Brest, France
75 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Thrombocytose Tumeurs du cerveau Lymphomes Carcinomes Syndromes myéloprolifératifs Thrombocytémie essentielle

Industries

MSD
1 collaboration(s)
Dernière en 2019
Novartis
1 collaboration(s)
Dernière en 2019
AstraZeneca
1 collaboration(s)
Dernière en 2019
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Progressive multifocal leukoencephalopathy in patients with chronic liver disease successfully treated with pembrolizumab.
Journal of neurology   24 décembre 2023
Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists?
Cancers   16 mai 2023
Histological and genetic characterization and follow-up of 130 patients with chronic triple-negative thrombocytosis.
Haematologica   01 novembre 2022
Endoscopic follow-up of low-grade precancerous bronchial lesions in high-risk patients: long-term results of the SELEPREBB randomised multicentre trial.
The European respiratory journal   15 septembre 2022
HER2 Mutated and Nonmutated Non-small Cell Lung Carcinomas Can Harbor Heterogeneous HER2 Gene Amplification and HER2 Protein Expression.
Applied immunohistochemistry & molecular morphology : AIMM   06 décembre 2021
Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosis.
Annals of hematology   05 octobre 2021
Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing.
Pathology   10 septembre 2021
EPR17341 and A7H6R pan-TRK Immunohistochemistry Result in Highly Different Staining Patterns in a Series of Salivary Gland Tumors.
Applied immunohistochemistry & molecular morphology : AIMM   25 août 2021
PD-L1 Immunohistochemistry-Discrepant Results Between Synchronous Tumor Samples May Cause More Treatment Choice Dilemmas Than Molecular Heterogeneity in Patients With Advanced Non-Small Cell Lung Cancers.
Applied immunohistochemistry & molecular morphology : AIMM   19 juillet 2021
Screening for NTRK-rearranged Tumors Using Immunohistochemistry: Comparison of 2 Different pan-TRK Clones in Melanoma Samples.
Applied immunohistochemistry & molecular morphology : AIMM   01 juin 2021